Cascinelli, N <br/><br/>
Evaluation of clinical efficacy and tolerability of intravenous high dose thymopentin in advanced melanoma patients.  [electronic resource] 

 -  Melanoma research  Feb 1998 
 - 83-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0960-8931 
<br/><br/><label>Standard No.: </label>10.1097/00008390-199802000-00014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Aged<br/>Female<br/>Humans<br/>Immunophenotyping<br/>Injections, Intravenous<br/>Lymphocytes, Tumor-Infiltrating--pathology<br/>Male<br/>Melanoma--immunology<br/>Middle Aged<br/>Skin Neoplasms--immunology<br/>Survival Rate<br/>Thymopentin--administration & dosage<br/>Treatment Outcome